000 01240 a2200349 4500
005 20250518051940.0
264 0 _c20200929
008 202009s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2019.07.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSuarez-Zuluaga, Diego A
245 0 0 _aAccelerating bioprocess development by analysis of all available data: A USP case study.
_h[electronic resource]
260 _bVaccine
_c11 2019
300 _a7081-7089 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBioreactors
_xvirology
650 0 4 _aChlorocebus aethiops
650 0 4 _aData Analysis
650 0 4 _aLeast-Squares Analysis
650 0 4 _aPoliovirus
_ximmunology
650 0 4 _aPoliovirus Vaccine, Inactivated
_ximmunology
650 0 4 _aPrincipal Component Analysis
_xmethods
650 0 4 _aVero Cells
700 1 _aBorchert, Daniel
700 1 _aDriessen, Nicole N
700 1 _aBakker, Wilfried A M
700 1 _aThomassen, Yvonne E
773 0 _tVaccine
_gvol. 37
_gno. 47
_gp. 7081-7089
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2019.07.026
_zAvailable from publisher's website
999 _c29932272
_d29932272